» Articles » PMID: 25392327

Higher Weight in Adolescence and Young Adulthood is Associated with an Earlier Age at Multiple Sclerosis Onset

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2014 Nov 14
PMID 25392327
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Growing evidence suggests an association between adolescent obesity and increased risk of multiple sclerosis (MS).

Objective: The objective of this paper is to investigate whether weight or body mass index (BMI) in adolescence and young adulthood was associated with age at MS symptom onset.

Methods: Our cohort is comprised of a sub-group of 184 women enrolled in the New York State MS Consortium registry. Individuals were asked to recall their weight at the time of first menstruation and at age 25. BMI was calculated accordingly for age 25. Regression analyses were carried out to investigate the association between weight or BMI and age at onset.

Results: Weight at menarche was significantly related to younger age at symptom onset (β = -0.073, p = 0.001). These results were also found at age 25 for weight (β = -0.080, p < 0.001) and BMI (β = -0.448, p = 0.001). Significantly earlier disease onset (26.9 years ±9.9) was observed in individuals who were overweight at 25 compared to those who were not overweight (32.1 years ±9.2, p = 0.006).

Conclusions: Women who reported higher weight in adolescence and BMI in early adulthood were younger at MS onset. Future research should investigate whether there is a causal link between body weight and MS, as prevention lifestyle and dietary interventions could be implemented.

Citing Articles

Obesity Control and Supplementary Nutraceuticals as Cofactors of Brain Plasticity in Multiple Sclerosis Populations.

Ciumarnean L, Sarb O, Draghici N, Salagean O, Milaciu M, Orasan O Int J Mol Sci. 2024; 25(20).

PMID: 39456690 PMC: 11507128. DOI: 10.3390/ijms252010909.


Investigation of serum levels of orexin-A, transforming growth factor β, and leptin in patients with multiple sclerosis.

Moharami S, Nourazarian A, Nikanfar M, Laghousi D, Shademan B, Khanghah O J Clin Lab Anal. 2021; 36(1):e24170.

PMID: 34894407 PMC: 8761413. DOI: 10.1002/jcla.24170.


Reproductive history and progressive multiple sclerosis risk in women.

Zeydan B, Atkinson E, Weis D, Smith C, Gazzuola Rocca L, Rocca W Brain Commun. 2021; 2(2):fcaa185.

PMID: 33409489 PMC: 7772117. DOI: 10.1093/braincomms/fcaa185.


Effects of dietary restriction on gut microbiota and CNS autoimmunity.

Cantoni C, Dorsett Y, Fontana L, Zhou Y, Piccio L Clin Immunol. 2020; 235:108575.

PMID: 32822833 PMC: 7889763. DOI: 10.1016/j.clim.2020.108575.


The FTO gene polymorphism rs9939609 is associated with obesity and disability in multiple sclerosis patients.

Al-Serri A, Alroughani R, Al-Temaimi R Sci Rep. 2019; 9(1):19071.

PMID: 31836807 PMC: 6911041. DOI: 10.1038/s41598-019-55742-2.